Najumudeen, Arafath K. http://orcid.org/0000-0002-3764-5721
,
Ceteci, Fatih
Fey, Sigrid K.
Hamm, Gregory
Steven, Rory T. http://orcid.org/0000-0002-6754-2424
Hall, Holly http://orcid.org/0000-0003-2779-2565
Nikula, Chelsea J. http://orcid.org/0000-0002-6817-2592
Dexter, Alex
Murta, Teresa
Race, Alan M. http://orcid.org/0000-0001-8996-2641
Sumpton, David http://orcid.org/0000-0002-9004-4079
Vlahov, Nikola
Gay, David M. http://orcid.org/0000-0002-7407-1245
Knight, John R. P. http://orcid.org/0000-0002-8771-5484
Jackstadt, Rene
Leach, Joshua D. G.
Ridgway, Rachel A.
Johnson, Emma R.
Nixon, Colin http://orcid.org/0000-0002-8085-2160
Hedley, Ann
Gilroy, Kathryn
Clark, William
Malla, Sudhir B. http://orcid.org/0000-0001-5862-3815
Dunne, Philip D.
Rodriguez-Blanco, Giovanny http://orcid.org/0000-0002-7154-7244
Critchlow, Susan E.
Mrowinska, Agata
Malviya, Gaurav http://orcid.org/0000-0003-0736-7991
Solovyev, Dmitry
Brown, Gavin
Lewis, David Y.
Mackay, Gillian M.
Strathdee, Douglas
Tardito, Saverio http://orcid.org/0000-0002-5294-8683
Gottlieb, Eyal http://orcid.org/0000-0002-9770-0956
Takats, Zoltan
Barry, Simon T.
Goodwin, Richard J. A. http://orcid.org/0000-0001-5699-8488
Bunch, Josephine
Bushell, Martin
Campbell, Andrew D. http://orcid.org/0000-0003-3930-1276
Sansom, Owen J. http://orcid.org/0000-0001-9540-3010
Article History
Received: 14 February 2020
Accepted: 20 November 2020
First Online: 7 January 2021
Competing interests
: S.T.B. is an employee and shareholder of AstraZeneca. The other authors declare no competing interests.